Anixa Biosciences Inc

ANIX NASDAQ
4.380
+0.170
+4.04%
已收盘, 16:00 07/23 EDT
开盘
4.230
昨收
4.210
最高
4.518
最低
4.209
成交量
3.66万
成交均量(3M)
7.88万
52周最高
6.86
52周最低
3.100
换手率
0.18%
市值
8,802.37万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Anixa Biosciences Inc ANIX股票价格,Anixa Biosciences Inc股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
展开 >

最近浏览

名称
价格
涨跌幅